+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Stereotactic Body Radiation Therapy (SBRT) For Centrally Located Primary and Recurrent Non-Small Cell Lung Cancer: Analysis of Toxicity and Local Control



Stereotactic Body Radiation Therapy (SBRT) For Centrally Located Primary and Recurrent Non-Small Cell Lung Cancer: Analysis of Toxicity and Local Control



International Journal of Radiation Oncology*biology*physics 93(3): E418-E419




(PDF emailed within 0-6 h: $19.90)

Accession: 064762921

Download citation: RISBibTeXText

DOI: 10.1016/j.ijrobp.2015.07.1614


Related references

Primary Study Endpoint Analysis for NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology*biology*physics 94(1): 5-6, 2016

Stereotactic Body Radiation Therapy (SBRT) for Primary Non-Small Cell Lung Cancer (NSCLC) and Pulmonary Metastases: Analysis of Outcomes and Predictive Factors for Local Control. International Journal of Radiation Oncology*biology*physics 87(2): S532-S533, 2013

Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 72(4): 967-971, 2008

Safety and Efficacy of Second Stereotactic Body Radiation Therapy (SBRT) for Local Recurrence of Non-small Cell Lung Cancer (NSCLC) or Lung Metastasis Previously Treated With SBRT. International Journal of Radiation Oncology*biology*physics 84(3): S569-S570, 2012

Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC). Acta Oncologica 57(11): 1567-1573, 2018

Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC). Anticancer Research 36(2): 825-828, 2016

Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1). International Journal of Clinical Oncology 22(5): 849-856, 2017

Stereotactic Body Radiotherapy for Centrally Located Primary Non-Small-Cell Lung Cancer: A Meta-Analysis. Clinical Lung Cancer 2019, 2019

Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non‒small-cell lung cancer or lung metastases. International Journal of Radiation Oncology, Biology, Physics 81(3): 856-862, 2011

Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 80(4): 1015-1022, 2011

Safety and Efficacy of Repeat Stereotactic Body Radiation Therapy (SBRT) for Local Recurrence of Non-Small Cell Lung Cancer (NSCLC) and Lung Metastasis. International Journal of Radiation Oncology*biology*physics 93(3): E409-E410, 2015

Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT. International Journal of Radiation Oncology, Biology, Physics 90(2): 402-406, 2014

Low Lung Density In Patients With Pulmonary Emphysema Increases The Risk Of Local Failure For Peripheral Early-stage Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Body Radiation Therapy (SBRT). International Journal of Radiation Oncology*biology*physics 81(2): S586-S587, 2011

Clinical Outcome and Toxicity in Central Located Stage I or Isolated Recurrent Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy. International Journal of Radiation Oncology*biology*physics 87(2): S514-S515, 2013

Stereotactic ablative radiation therapy for centrally located recurrences of non-small cell lung cancer: in regard to Chang et al. International Journal of Radiation Oncology, Biology, Physics 89(5): 1141-1142, 2014